BRICS supports proposal by India, South Africa to temporarily waive patents on COVID vaccines: A joint statement said the foreign ministers of the grouping also resolved to combat terrorism in all its forms and manifestations. Source: "South Africa" - BingNews … [Read more...] about SA News: BRICS supports proposal by India, South Africa to temporarily waive patents on COVID vaccines
waive
African Union backs call to waive IP rights on COVID-19 drugs
African Union backs call to waive IP rights on COVID-19 drugs: Johannesburg, Gauteng, South Africa in the news: African Union backs call to waive IP rights on COVID-19 drugs: JOHANNESBURG (Reuters) – The African Union is backing calls for drugmakers to waive some intellectual property rights on COVID-19 medicines and vaccines to speed up their rollout to poor countries, … [Read more...] about African Union backs call to waive IP rights on COVID-19 drugs
SA News: Waive property rights from vaccines, India, South Africa urge WTO. All you need to know
Waive property rights from vaccines, India, South Africa urge WTO. All you need to know: Once an effective vaccine is manufactured, there will be legal battles over patent which will make its distribution difficult, India and South Africa have pointed out. Source: "South Africa" - BingNews India and S.Africa ask WTO to waive rules to aid...: India and South Africa want … [Read more...] about SA News: Waive property rights from vaccines, India, South Africa urge WTO. All you need to know
SA News: India and South Africa ask WTO to waive rules to aid COVID-19 drug production
India and South Africa ask WTO to waive rules to aid COVID-19 drug production: India and South Africa want the World Trade Organization (WTO) to waive intellectual property rules to make it easier for developing countries to ... Source: "South Africa" - BingNews India, South Africa ask WTO to waive rules to aid COVID-19 drug production: In their letter dated Oct. 2 the … [Read more...] about SA News: India and South Africa ask WTO to waive rules to aid COVID-19 drug production